LINC02172

Across TCGA pan-cancer cohorts, LINC02172 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02172 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher LINC02172 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02172 expression acts as an unfavorable survival marker, although some lineages such as SARC and BRCA show a favorable association.

LUSC, HNSC, and THCA are the cancer types where LINC02172 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.319	0.464	.001	51	view →
HNSC	OS	Tertile	III,IV	0.558	0.749	.004	43	view →
THCA	OS	Quartile	All	0.863	0.980	.002	43	view →
KICH	OS	Tertile	II,III,IV	0.388	0.857	.001	42	view →
THYM	OS	Quartile	II,III,IV	0.869	0.992	.010	20	view →
STAD	OS	Tertile	IV	0.133	0.575	.001	18	view →
SARC	DFS	Median	All	0.541	0.245	.001	11	view →
PAAD	OS	Median	II,III,IV	0.384	0.585	.013	10	view →
BRCA	DFS	Median	III,IV	0.859	0.737	.006	10	view →
SKCM	OS	Median	III,IV	0.503	0.320	.015	8	view →
OV	OS	Quartile	II,III,IV	0.636	0.740	.036	4	view →
PRAD	OS	Median	All	0.977	1.000	.016	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02172–LUSC (OS)

Open the LUSC breakdown →